Reflections and Future Focus

This article is part of the Annual Report 2019

The future focus of the Executive Management Team will be to maintain the good collaboration with the members of the DDA bodies, the junior diabetes researchers and the main collaborators of the DDA.

Another focus point will be the reelection of the four DDA bodies in 2021, as these bodies were appointed for a period of two and a half years. The Executive Management Team will start up this process in 2020.

As suggested by the International Advisory Board, the DDA is now at a point where it can begin to evaluate the wider impact and influence of its activities. Preliminary discussions on this issue were already opened in the National Advisory Forum and the International Advisory Board in 2019, and these discussions will continue in 2020 with the aim to develop an impact strategy for the DDA.

Finally, the focus of the DDA bodies in 2020 will be to discuss how to strengthen the collaboration with the life sciences industry, and how to attract more industrial PhD students and postdocs for the DDA industrial grants. Furthermore, the DDA bodies will discuss how to adopt a more strategic approach in connection with collaboration with international research institutions for organising the educational and networking activities. In conclusion, the Executive Management Team will continue to implement suggestions from the DDA bodies in the activities and ensure that the overall strategy decided by the Board of Directors is implemented.